Cargando…
Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients
OBJECTIVE: To evaluate differences in thromboinflammatory biomarkers between patients with severe coronavirus disease 2019 (COVID-19) infection/death and mild infection. PATIENTS AND METHODS: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, EBSCO, Web of Science, and CINAHL databases...
Autores principales: | Chaudhary, Rahul, Garg, Jalaj, Houghton, Damon E., Murad, M. Hassan, Kondur, Ashok, Chaudhary, Rohit, Wysokinski, Waldemar E., McBane, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869679/ https://www.ncbi.nlm.nih.gov/pubmed/33585800 http://dx.doi.org/10.1016/j.mayocpiqo.2021.01.009 |
Ejemplares similares
-
Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021) -
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
por: Pasha, Ahmed K., et al.
Publicado: (2021) -
Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
por: Chaudhary, Rahul, et al.
Publicado: (2020) -
Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Gaddh, Manila, et al.
Publicado: (2023) -
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)